Clinical trials
Observational trials in Slovenia with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 9 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 3 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 54 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Medical Centre Ljubljana | 23 |
| Institute of Oncology Ljubljana | 3 |
| The University Clinic of Pulmonary and Allergic Diseases Golnik | 3 |
| Blood Transfusion Centre of Slovenia | 2 |
| General and Teaching Hospital Celje | 2 |
| IRCCS Burlo Garofolo | 2 |
| Institute of Nutrition, Slovenia (Nutris) | 2 |
| Science and Research Centre Koper | 2 |
| AO Clinical Investigation and Publishing Documentation | 1 |
| Andrea Romano | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 3 |
| Neoplasms | 3 |
| Atrial Fibrillation | 2 |
| COVID-19 | 2 |
| Cognitive Dysfunction | 2 |
| Diabetes Mellitus, Type 1 | 2 |
| Encephalitis, Tick-Borne | 2 |
| Hidradenitis Suppurativa | 2 |
| Sarcopenia | 2 |
| Acute Coronary Syndrome | 1 |
Trials
Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.